In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works ...
An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say.
The 54-year-old former U.S. senator from Nebraska was diagnosed with terminal pancreatic cancer in December. A clinical trial drug is shrinking his tumors.
The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...
When mantle cell lymphoma stops responding to treatment, the options narrow fast. This rare but aggressive form of ...
A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...
Doctors are testing a new three-drug treatment that may help patients with cancer whose original source cannot be found.
An innovative blood test could detect hidden signs of cancer spreading earlier than CT scans and help adjust treatments in a timely manner.